
    
      The PROTEMBO SF Trial is a prospective, single arm, observational, multi-center,
      intention-to-treat study of the safety and feasibility of the ProtEmbo Cerebral Protection
      System in subjects with severe symptomatic native aortic valve stenosis indicated for TAVR.
    
  